Copyright Reports & Markets. All rights reserved.

Global Alosetron Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Alosetron Market Overview

      • 1.1 Product Overview and Scope of Alosetron
      • 1.2 Alosetron Segment by Type
        • 1.2.1 Global Alosetron Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 0.5 Tablets
        • 1.2.3 1 mg Tablets
      • 1.3 Alosetron Segment by Application
        • 1.3.1 Alosetron Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Drugstore
      • 1.4 Global Alosetron Market by Region
        • 1.4.1 Global Alosetron Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Alosetron Market Size
        • 1.5.1 Global Alosetron Revenue (2014-2025)
        • 1.5.2 Global Alosetron Production (2014-2025)

      2 Global Alosetron Market Competition by Manufacturers

      • 2.1 Global Alosetron Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Alosetron Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Alosetron Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Alosetron Production Sites, Area Served, Product Types
      • 2.5 Alosetron Market Competitive Situation and Trends
        • 2.5.1 Alosetron Market Concentration Rate
        • 2.5.2 Alosetron Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Alosetron Production Market Share by Regions

      • 3.1 Global Alosetron Production Market Share by Regions
      • 3.2 Global Alosetron Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Alosetron Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Alosetron Production
        • 3.4.1 North America Alosetron Production Growth Rate (2014-2019)
        • 3.4.2 North America Alosetron Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Alosetron Production
        • 3.5.1 Europe Alosetron Production Growth Rate (2014-2019)
        • 3.5.2 Europe Alosetron Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Alosetron Production (2014-2019)
        • 3.6.1 China Alosetron Production Growth Rate (2014-2019)
        • 3.6.2 China Alosetron Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Alosetron Production (2014-2019)
        • 3.7.1 Japan Alosetron Production Growth Rate (2014-2019)
        • 3.7.2 Japan Alosetron Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Alosetron Consumption by Regions

      • 4.1 Global Alosetron Consumption by Regions
      • 4.2 North America Alosetron Consumption (2014-2019)
      • 4.3 Europe Alosetron Consumption (2014-2019)
      • 4.4 China Alosetron Consumption (2014-2019)
      • 4.5 Japan Alosetron Consumption (2014-2019)

      5 Global Alosetron Production, Revenue, Price Trend by Type

      • 5.1 Global Alosetron Production Market Share by Type (2014-2019)
      • 5.2 Global Alosetron Revenue Market Share by Type (2014-2019)
      • 5.3 Global Alosetron Price by Type (2014-2019)
      • 5.4 Global Alosetron Production Growth by Type (2014-2019)

      6 Global Alosetron Market Analysis by Applications

      • 6.1 Global Alosetron Consumption Market Share by Application (2014-2019)
      • 6.2 Global Alosetron Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Alosetron Business

      • 7.1 Sebela Pharmaceuticals
        • 7.1.1 Sebela Pharmaceuticals Alosetron Production Sites and Area Served
        • 7.1.2 Alosetron Product Introduction, Application and Specification
        • 7.1.3 Sebela Pharmaceuticals Alosetron Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Amneal
        • 7.2.1 Amneal Alosetron Production Sites and Area Served
        • 7.2.2 Alosetron Product Introduction, Application and Specification
        • 7.2.3 Amneal Alosetron Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Par Pharmaceutical
        • 7.3.1 Par Pharmaceutical Alosetron Production Sites and Area Served
        • 7.3.2 Alosetron Product Introduction, Application and Specification
        • 7.3.3 Par Pharmaceutical Alosetron Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 West-Ward Pharmaceuticals
        • 7.4.1 West-Ward Pharmaceuticals Alosetron Production Sites and Area Served
        • 7.4.2 Alosetron Product Introduction, Application and Specification
        • 7.4.3 West-Ward Pharmaceuticals Alosetron Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served

      8 Alosetron Manufacturing Cost Analysis

      • 8.1 Alosetron Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Alosetron
      • 8.4 Alosetron Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Alosetron Distributors List
      • 9.3 Alosetron Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Alosetron Market Forecast

      • 11.1 Global Alosetron Production, Revenue Forecast
        • 11.1.1 Global Alosetron Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Alosetron Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Alosetron Price and Trend Forecast (2019-2025)
      • 11.2 Global Alosetron Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Alosetron Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Alosetron Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Alosetron Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Alosetron Production, Revenue Forecast (2019-2025)
      • 11.3 Global Alosetron Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Alosetron Consumption Forecast (2019-2025)
        • 11.3.2 Europe Alosetron Consumption Forecast (2019-2025)
        • 11.3.3 China Alosetron Consumption Forecast (2019-2025)
        • 11.3.4 Japan Alosetron Consumption Forecast (2019-2025)
      • 11.4 Global Alosetron Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Alosetron Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Alosetron (original brand name: Lotronex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted.

        The global Alosetron market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Alosetron volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alosetron market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Sebela Pharmaceuticals
        Amneal
        Par Pharmaceutical
        West-Ward Pharmaceuticals
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        0.5 Tablets
        1 mg Tablets

        Segment by Application
        Hospital
        Drugstore

        Buy now